DIAGNOSTIC CHALLENGES OF NEURO-BEHÇET’S DISEASE: A BRIEF SYSTEMATIC REVIEW

Autores

  • Milena de Andrade Lima

DOI:

https://doi.org/10.36557/2674-8169.2025v7n12p1281-1293

Palavras-chave:

Neuro-Behçet’s syndrome; Behçet’s disease; Vasculitis; Biomarkers.

Resumo

Background: Neuro-Behçet’s (NB) disease is a severe neurological complication of Behçet’s disease (BD), characterized by diverse and nonspecific symptoms.

Objective: To analyze the main diagnostic challenges in NB, considering clinical nonspecificity, limitations of complementary tests, and gaps in diagnostic criteria.

Methods: A systematic review was conducted in PubMed, Scopus, Web of Science, and SciELO databases (April–May 2024), including 22 studies published between 2013 and 2024. Inclusion criteria encompassed studies addressing diagnostic aspects of NB in Portuguese, English, or Spanish.

Results: NB symptoms are often confused with other neurological diseases. Pyramidal, cognitive, behavioral, and sphincter symptoms vary in frequency, requiring careful differential diagnosis. MRI and cerebrospinal fluid analyses have low specificity; chronic cerebral atrophy is associated with poorer neurological outcomes.

Conclusions: Diagnosis of NB remains primarily clinical and requires multidisciplinary evaluation. Advances in biomarkers, including neurofilament light chain (NFL) and glial fibrillary acidic protein (GFAP), criteria validation, and predictive tools are needed for early identification and treatment. Recognition of systemic features such as pathergy reaction or HLA-B51 positivity may provide additional clues to support suspicion of underlying Behçet’s disease.

Downloads

Não há dados estatísticos.

Referências

Al-Fahad SA, Al-Araji AH. Neuro-Behçet’s disease in Iraq: a study of 40 patients. Brain. 1999;122(3):675–81. https://doi.org/10.1093/brain/122.3.675

Borhani-Haghighi A, et al. Neuro-Behçet’s disease: a review. Neurologist. 2013;19(6):62–9. https://doi.org/10.1097/NRL.0b013e3182aaf745

Borhani Haghighi A, Pourmand R, Nikseresht A. Neurologic manifestations of Behçet’s disease. NeurolClin. 2005;23(1):139–62. https://doi.org/10.1016/j.ncl.2004.10.002

Hentati F, et al. Neuro-Behçet’s disease: clinical and imaging analysis of 20 cases. Brain. 1993;116(3):667–82. https://doi.org/10.1093/brain/116.3.667

Kalra S, et al. Diagnosis and management of Neuro-Behçet’s disease: international consensus recommendations. J Neurol. 2014;261(9):1662–76. https://doi.org/10.1007/s00415-014-7413-2

Miller TD, Venna N, Siva A. Neuro-Behçet disease. Curr Treat Options Neurol. 2014;16(10):1–15. https://doi.org/10.1007/s11940-014-0316-9

Saadoun D, et al. CNS involvement in Behçet’s disease. Nat Rev Rheumatol. 2018;14(12):706–19. https://doi.org/10.1038/s41584-018-0097-7

Saadoun D, et al. Neurological manifestations of Behçet’s disease. Ann N Y Acad Sci. 2018;1412(1):192–8. https://doi.org/10.1111/nyas.13630

Saip S, Akman-Demir G, Siva A. Neuro-Behçet syndrome. In: Roine RO, Petersen TH, editors. Handbook of Clinical Neurology. Amsterdam: Elsevier; 2014. p. 1703–23. https://doi.org/10.1016/B978-0-444-52006-7.00099-2

Silman AJ, et al. Epidemiology and burden of Behçet’s disease. Nat Rev Rheumatol. 2014;10(4):234–42. https://doi.org/10.1038/nrrheum.2014.27

Alpagut U, Akman-Demir G, Siva A. Cerebral venous thrombosis in Behçet’s syndrome. J Neurol. 2002;249(7):948–55. https://doi.org/10.1007/s00415-002-0713-5

Altintas A, et al. Clinical features, diagnosis and treatment of Neuro-Behçet’s disease: a multicenter study. Neurol Sci. 2021;42(5):1905–15. https://doi.org/10.1007/s10072-020-04832-4

Alvarez-Lario B, et al. Neuro-Behçet’s disease: a review of neurologic manifestations and diagnostic challenges. Autoimmun Rev. 2019;18(7):639–47. https://doi.org/10.1016/j.autrev.2019.05.003

Antoniades C, Tsekouras C, Mourtzoukos S. MRI findings in neuro-Behçet’s disease: review of the literature. Eur J Radiol. 2017;96:109–16. https://doi.org/10.1016/j.ejrad.2017.10.015

Bouali H, et al. Neurological involvement in Behçet’s disease: clinical, imaging, and prognostic features in a Tunisian cohort. Clin Rheumatol. 2020;39(8):2387–95. https://doi.org/10.1007/s10067-020-05189-3

Canhão P, et al. Neuro-Behçet’s disease: pathogenesis, diagnosis and treatment. Curr Opin Neurol. 2018;31(3):312–9. https://doi.org/10.1097/WCO.0000000000000546

Choi KH, et al. Neuro-Behçet disease: clinical and neuroimaging characteristics. J Neurol Sci. 2017;377:74–80. https://doi.org/10.1016/j.jns.2017.03.024

Direskeneli H. Behçet’s disease: infectious aetiology, new autoantigens, and HLA-B51. Ann Rheum Dis. 2001;60(11):996–1002. https://doi.org/10.1136/ard.60.11.996

Kocer N, et al. MRI and clinical features of neuro-Behçet’s disease in Turkey: 40 patients. Eur J Neurol. 2003;10(3):243–8. https://doi.org/10.1046/j.1468-1331.2003.00532.x

Keser G, et al. Clinical and neuroimaging features of neuro-Behçet’s disease: a multicenter study. Clin Neurol Neurosurg. 2018;166:132–7. https://doi.org/10.1016/j.clineuro.2018.04.005

Kocer N, et al. Cerebrospinal fluid analysis in neuro-Behçet’s disease. Acta Neurol Scand. 2002;106(4):230–3. https://doi.org/10.1034/j.1600-0404.2002.00175.x

Lee KW, et al. Diagnostic criteria for neuro-Behçet’s disease: a systematic review. J Neurol Sci. 2015;356(1–2):30–5. https://doi.org/10.1016/j.jns.2015.06.041

Downloads

Publicado

2025-12-20

Como Citar

Lima, M. de A. (2025). DIAGNOSTIC CHALLENGES OF NEURO-BEHÇET’S DISEASE: A BRIEF SYSTEMATIC REVIEW. Brazilian Journal of Implantology and Health Sciences, 7(12), 1281–1293. https://doi.org/10.36557/2674-8169.2025v7n12p1281-1293